Multidrug-resistant tuberculosis
2008

Understanding Multidrug-Resistant Tuberculosis

Sample size: 97 publication Evidence: moderate

Author Information

Author(s): Ellen M Zager, Ruth McNerney

Primary Institution: London School of Hygiene & Tropical Medicine

Hypothesis

Current methods of describing the epidemiology of drug-resistant tuberculosis are inadequate.

Conclusion

The problem of drug-resistant tuberculosis in sub-Saharan Africa is more critical than previously perceived.

Supporting Evidence

  • MDR-TB has been reported in all regions of the world.
  • Sub-Saharan Africa has some of the highest rates of transmitted MDR-TB.
  • Current reporting methods do not reflect the true burden of drug-resistant tuberculosis.

Takeaway

Tuberculosis is a big problem, and some areas thought to have low drug resistance actually have high rates of drug-resistant cases.

Methodology

Re-analysis of global surveillance data on drug-resistant tuberculosis incidence.

Potential Biases

Sampling strategies for previously treated cases varied, affecting representativeness.

Limitations

Data on previously treated cases was not included, leading to potential underestimation of MDR-TB incidence.

Participant Demographics

Data compiled from 97 countries or geographical settings.

Digital Object Identifier (DOI)

10.1186/1471-2334-8-10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication